Liraglutide ameliorates lipotoxicity-induced inflammation through the mTORC1 signalling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liraglutide ameliorates lipotoxicity-induced inflammation through the mTORC1 signalling pathway

Published:2020-11 Issue: Volume:133 Page:170375
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Ao Na,Ma Zhuoqi,Yang Jing,Jin Shi,Zhang Keying,Luo Enjie,Du Jian

Funder

China Liaoning Education Department Project

China Liaoning Provincial Doctor Launching Fund

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference44 articles.

1. Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease;Sun;Expert Opin. Ther. Targets,2016

2. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD);Buzzetti;Metab. Clin. Exp.,2016

3. Lipotoxicity and the gut-liver axis in NASH pathogenesis;Marra;J. Hepatol.,2018

4. The TLR4-IRE1α pathway activation contributes to palmitate-elicited lipotoxicity in hepatocytes;Shen;J. Cell. Mol. Med.,2018

5. Twenty-five years of mTOR: uncovering the link from nutrients to growth;Sabatini;Proc. Natl. Acad. Sci. U.S.A.,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking longevity with GLP-1: A key to turn back the clock?;Maturitas;2024-08

2. Exploring the multifaceted role of ginkgolides and bilobalide from Ginkgo biloba in mitigating metabolic disorders;Food Science and Biotechnology;2024-07-10

3. The role and mechanism of pyroptosis and potential therapeutic targets in non-alcoholic fatty liver disease (NAFLD);Frontiers in Cell and Developmental Biology;2024-07-03

4. Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease;Hormones;2024-03-12

5. GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes;Cells;2023-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3